Percutaneously implantable catheter-port system: preliminary technical results

Area of Science:

• Vascular Surgery
• Medical Devices
• Oncology

Background:

• Repeated local-regional arterial infusions are crucial for managing various diseases, including malignant and peripheral arterial conditions.
• Percutaneously implantable catheter-port systems offer a potential solution for long-term vascular access.
• Evaluating the safety and functionality of novel medical devices is essential for clinical adoption.

Purpose of the Study:

• To assess the safety and functional performance of a newly developed percutaneously implantable catheter-port system.
• To evaluate the system's suitability for patients requiring repeated local-regional arterial infusions.
• To identify any complications associated with the use of this catheter-port system.

Main Methods:

• A prospective study involving 44 patients with diverse conditions requiring repeated arterial infusions.
• Percutaneous implantation of a novel catheter-port system.
• Monitoring patients for device-related complications and overall system performance during a follow-up period (mean 177 days, maximum 542 days).

Main Results:

• The catheter-port system was implanted in 44 patients (32 malignant disease, 11 peripheral arterial disease, 1 asthmatic).
• Infection occurred in two patients, and catheter-related complications were noted in 10 patients.
• No instances of port migration or leakage were reported, indicating good device integrity.

Conclusions:

• The percutaneously implantable catheter-port system demonstrates a favorable safety profile for patients requiring repeated arterial infusions.
• The system is considered easy to handle by clinicians, facilitating its use in managing complex vascular access needs.
• Further research may explore long-term outcomes and broader applications of this catheter-port technology.